CorMedix ($CRMD) earnings preview shows mixed signals with analyst estimate revisions and negative technicals.
Source Post
CorMedix $CRMD Q1 2026 Earnings Preview
Investing Portfolio PathwayMay 13, 2026
CorMedix ($CRMD) is set to report Q1 2026 earnings on May 14th. The company previously beat revenue estimates but missed earnings estimates. Analysts have lowered estimates for the upcoming quarter, and the stock shows negative relative strength with high short interest.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.